LncRNA Phosphatase and Tensin Homolog Induced Kinase 1-AS Promotes Insulin Like Growth Factor 1 Receptor Expression Through Sponge miR-98-5p and Contributes to Bladder Cancer Progression

被引:0
作者
Wang, ShunPing [1 ]
Cheng, DanPing [1 ]
Zheng, Bin [1 ]
机构
[1] Ningbo Urol & Nephrol Hosp, Dept Urol Surg, Ningbo 315000, Zhejiang, Peoples R China
关键词
LncRNA PINK1-AS; IGF1R; miR-98-5p; Bladder Cancer; LONG NONCODING RNA; PROLIFERATION; CELLS;
D O I
10.1166/jbt.2023.3259
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background: LncRNA PINK1-AS is an identified key modifier in cancers, but its biological func-tion in bladder cancer (BC) remains unclear. The current work tried to explore the function and mechanism of PINK1-AS in BC. Methods: Fifty-five pairs of BC tissue and matched para-cancer normal tissue were excised to analyze PINK1-AS, miR-98-5p, and IGF1R expression. Based on T24 cells, the proliferative, apoptotic, invasive, and migratory activities were evaluated by CCK-8, flow cytometry, and Transwell assay correspondingly. RIP and dual luciferase reporter assays verified binding relationships between genes. Results: PINK1-AS expression was abnormally high in BC tis-sues, and was associated with TNM staging and lymph node metastasis in BC patients. PINK1-AS knockdown delayed the malignant progression in BC. Overexpressing PINK1-AS had the opposite effect. The impacts of silencing or promoting PINK1-AS on BC were mitigated by overexpression of IGF1R and miR-98-5p, respectively. PINK1-AS was competitively bound to miR-98-5p to mediate IGF1R expression. Conclusion: Targeting the abnormally overexpressed lncRNA, PINK1-AS, can IP: 203.8.109.20 On: Tue, 18 Apr 2023 08:46:03 Copyright: American Scientific Publishers release the inhibition of IGF1R by miR-98-5p, thereby promoting BC malignancy. PINK1-AS/miR-Delivered by Ingenta 98-5p/IGF1R axis can be used as a potential therapeutic target for BC.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 36 条
[1]   The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma [J].
Ariel, I ;
Sughayer, M ;
Fellig, Y ;
Pizov, G ;
Ayesh, S ;
Podeh, D ;
Libdeh, BA ;
Levy, C ;
Birman, T ;
Tykocinski, ML ;
de Groot, N ;
Hochberg, A .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (06) :320-323
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Long noncoding RNAs: functions and mechanisms in colon cancer [J].
Chen, Sian ;
Shen, Xian .
MOLECULAR CANCER, 2020, 19 (01)
[4]   Recent advances in the diagnosis and treatment of bladder cancer [J].
Cheung, Grace ;
Sahai, Arun ;
Billia, Michele ;
Dasgupta, Prokar ;
Khan, Muhammad S. .
BMC MEDICINE, 2013, 11
[5]   BLADDER CANCER [J].
Grayson, Michelle .
NATURE, 2017, 551 (7679) :S33-S33
[6]  
Han Li, 2021, J BUON, V26, P1782
[7]   miRNA interplay: mechanisms and consequences in cancer [J].
Hill, Meredith ;
Tran, Nham .
DISEASE MODELS & MECHANISMS, 2021, 14 (04)
[8]   microRNA involvement in human cancer [J].
Iorio, Marilena V. ;
Croce, Carlo M. .
CARCINOGENESIS, 2012, 33 (06) :1126-1133
[9]   CHARACTERIZATION OF INSULIN-LIKE GROWTH FACTOR-I BINDING-SITES IN HUMAN BLADDER-CANCER CELL-LINES [J].
IWAMURA, M ;
ISHIBE, M ;
SLUSS, PM ;
COCKETT, ATK .
UROLOGICAL RESEARCH, 1993, 21 (01) :27-32
[10]  
Jin Z., 2022, J HIGH ENERGY PHYS, V23, P10